Conversely, bioactive components in shiitake mushrooms suppress breast cancer progression by regulating the Nur77/HIF-1α signaling axis, particularly through promoting Nur77-dependent ubiquitin-proteasome degradation pathways (Zhang et al., 2020). Here, NR4A1 is linked to breast cancer.